Inactive Instrument

Analyst Reco. StemCells Inc Nasdaq

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

07-08	Microbot Medical Enrolls First Patient in Human Clinical Trial of Liberty Surgical System	MT
07-08	Microbot Medical Enrolled the First Patient in Its Pivotal Human Clinical Trial	CI

HC Wainwright Adjusts Microbot Medical's Price Target to $7 From $8, Keeps Buy Rating	04-16	MT
HC Wainwright Adjusts Price Target on Microbot Medical to $8 From $20, Keeps Buy Rating	23-05-09	MT

No results for this search